New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
08:10 EDTMDT, COVMedtronic price target raised to $73 from $66 at Oppenheimer
Oppenheimer increased its price target on Medtronic (MDT), citing cost savings and tax benefits from the company's acquisition of Covidien (COV). The firm keeps an Outperform rating on Medtronic.
News For MDT;COV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
08:37 EDTMDTFlex Pharma announces investment from Medtronic
Subscribe for More Information
March 2, 2015
12:59 EDTMDTAppeals court ruling a positive for NuVasive, says Wells Fargo
Subscribe for More Information
12:54 EDTMDTNuVasive gets mixed appeals court ruling in patent fight with Medtronic
Subscribe for More Information
08:55 EDTMDTEdwards Lifesciences Medtronic likely to get positive catalyst, says Wells Fargo
Subscribe for More Information
February 27, 2015
09:02 EDTMDTMedtronic announces Irish High Court approval of share premium reduction
Subscribe for More Information
February 24, 2015
13:02 EDTMDTMedtronic confirms FDA approval of VenaSeal closure system
Subscribe for More Information
February 23, 2015
08:40 EDTMDTMedtronic acquires Advanced Uro-Solutions, terms not disclosed
Medtronic announced that it has acquired Advanced Uro-Solutions, a privately-held developer of neurostimulation products for the treatment of bladder control issues based in Elizabethton, Tennessee. Terms of the acquisition agreement, which closed in December 2014, were not disclosed.
February 20, 2015
12:19 EDTMDTFDA approves closure system to permanently treat varicose veins
Subscribe for More Information
February 19, 2015
16:15 EDTMDTMedtronic SANTE trial data show sustained safety, improvements in QOLIE-31
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use